75N95024F00007↗

Name: 75N95024F00007: Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (Ctn-0100). August 15, 2024 to March 31, 2028. N01Da-22-2253. Task Order No. 75N95024F00007 (To23).
Creator: SpendQuery

OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO. 75N95024F00007 (TO23).

Delivery Order · National Institutes of Health · to The Emmes Company, LLC (UEI NBQCBJ6FXBU4) · data as of 2026-09-30

Obligated to date$1.86M3 actions

Current value$1.86Mwith options exercised

Period2024-08-15 → 2028-03-31current end date

Up for re-bid: ends 2028-03-31. Recompete brief → · Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories ↗

What it is

Product or service: Health R&D Services; Health Care Services; Basic Research (PSC AN11)
Industry: Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
Contracting office: National Institutes of Health Nida (75N950)
Competition: Full and open competition
Pricing: Cost plus fixed fee
How it was bought: Single-award IDIQ · under 75N95022D00017
Solicitation: 75N95024F00007
Where the work is: Montgomery, MD · district MD-08
Topics: opioids

Obligations by fiscal year

FY2024$1.51M

FY2026$349.7K

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

3 actions since 2024-08-14. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-08-19	P00002	Option exercised	$174.8K	OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO. 75N95024F00007 (TO23).
2026-07-01	P00001	Change order	$174.8K	OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO. 75N95024F00007 (TO23).
2024-08-14	0		$1.51M	OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO. 75N95024F00007 (TO23).

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗